Tag: investigator sites

KPIs and Feedback Loops to Measure Investigator Meeting Impact KPIs and Feedback Loops to Measure Investigator Meeting Impact In the rapidly evolving landscape of clinical research, it is essential for clinical operations, regulatory affairs, and medical affairs professionals to employ efficient and effective strategies for assessing the impact of investigator meetings (IMs). This article provides…

Read More “KPIs and Feedback Loops to Measure Investigator Meeting Impact” »

Coordinating CRO, Vendor and Sponsor Roles at SIVs Coordinating CRO, Vendor and Sponsor Roles at SIVs In the complex landscape of clinical trials, the Site Initiation Visit (SIV) serves as a critical milestone in ensuring that all parties involved are aligned and prepared for the upcoming study. Coordination among the Contract Research Organization (CRO), the…

Read More “Coordinating CRO, Vendor and Sponsor Roles at SIVs” »

Regional and Cultural Considerations for Global Investigator Meetings Regional and Cultural Considerations for Global Investigator Meetings In the rapidly evolving realm of clinical research, conducting investigator meetings is a pivotal aspect for the successful initiation and ongoing management of clinical trials, such as those focused on alopecia areata clinical trials. Understanding regional and cultural considerations…

Read More “Regional and Cultural Considerations for Global Investigator Meetings” »

Integrating Patient Voice and Advocacy Into Investigator Meetings Integrating Patient Voice and Advocacy Into Investigator Meetings The integration of patient perspectives into clinical research processes is increasingly recognized as vital for the success of clinical trials. The destiny breast04 clinical trial, among others, exemplifies the importance of engaging with patients and advocates during key phases…

Read More “Integrating Patient Voice and Advocacy Into Investigator Meetings” »

Documenting Attendance, Training and Competency at IMs and SIVs Documenting Attendance, Training and Competency at IMs and SIVs Introduction to IMs and SIVs The initiation of clinical trials relies heavily on the effective coordination and management of various activities. One crucial aspect that contributes to this is the documentation of attendance, training, and competency at…

Read More “Documenting Attendance, Training and Competency at IMs and SIVs” »

Managing Protocol Changes Between Investigator Meeting and Site Initiation Visit In the landscape of clinical trials, ensuring compliance with regulatory requirements is paramount. For professionals involved in clinical operations, regulatory affairs, and medical affairs, effective management of protocol changes between the Investigator Meeting (IM) and Site Initiation Visit (SIV) is critical. This guide presents a…

Read More “Managing Protocol Changes Between Investigator Meeting and SIV” »

Using Investigator Meetings to Clarify Complex Endpoints and Assessments Using Investigator Meetings to Clarify Complex Endpoints and Assessments Investigator meetings are critical components in the development of successful clinical trials, particularly for complex studies involving nuanced endpoints and assessments. These meetings serve as a platform for site management organizations, clinical research teams, and investigators to…

Read More “Using Investigator Meetings to Clarify Complex Endpoints and Assessments” »

Engagement Tactics to Turn Investigators Into Study Champions Engagement Tactics to Turn Investigators Into Study Champions In the ever-evolving landscape of clinical research, the role of investigators is paramount. Not only do they conduct the trials, but they also influence patient recruitment, retention, and overall study success. Proper engagement strategies can turn an ordinary investigator…

Read More “Engagement Tactics to Turn Investigators Into Study Champions” »

Standardized SIV Checklists for Drug, Device and Combination Product Trials Standardized SIV Checklists for Drug, Device and Combination Product Trials The initiation of clinical trials is a critical activity that requires meticulous planning and execution. Site Initiation Visits (SIVs) represent a vital stage in the clinical trial lifecycle, ensuring that clinical sites are prepared to…

Read More “Standardized SIV Checklists for Drug, Device and Combination Product Trials” »